Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Goebeler

Showing results (261-270 of 310) with videos related to

Pageof 31
Sort By:
Cancers|June 16, 2019
Uveal Melanoma: A European Network to Face the Many Challenges of a Rare CancerSophie Piperno-Neumann, Jose Maria Piulats, Matthias Goebeler, et al.
JCI Insight|April 29, 2025
Epac1 contributes to apremilast-mediated rescue of pemphigus autoantibody-induced loss of keratinocyte adhesionAnna M Sigmund, Franziska C Bayerbach, Daniela Kugelmann, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 4, 2020
Michael P Schön, Carola Berking, Tilo Biedermann, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 8, 2020
COVID-19 and immunological regulations - from basic and translational aspects to clinical implicationsMichael P Schön, Carola Berking, Tilo Biedermann, et al.
Frontiers in Immunology|December 27, 2021
NFAT5 Controls the Integrity of EpidermisKhalid Muhammad, Delicia Xavier, Stefan Klein-Hessling, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 4, 2007
Recommendations for the use of immunoapheresis in the treatment of autoimmune bullous diseasesDetlef Zillikens, Kurt Derfler, Rüdiger Eming, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 16, 2020
S2k guidelines for the treatment of pemphigus vulgaris/foliaceus and bullous pemphigoid: 2019 updateEnno Schmidt, Michael Sticherling, Miklós Sárdy, et al.
Expert Review of Clinical Immunology|April 29, 2025
Safety profile of efgartigimod from global clinical trials across multiple immunoglobulin G-mediated autoimmune diseasesKelly G Gwathmey, Catherine M Broome, Matthias Goebeler, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 16, 2020
Enno Schmidt, Michael Sticherling, Miklós Sárdy, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 28, 2015
S2k guidelines for the treatment of pemphigus vulgaris/foliaceus and bullous pemphigoidRüdiger Eming, Michael Sticherling, Silke C Hofmann, et al.
Pageof 31

Showing results (261-270 of 310) with videos related to

Sort By:
Pageof 31
Cancers|June 16, 2019
Uveal Melanoma: A European Network to Face the Many Challenges of a Rare CancerSophie Piperno-Neumann, Jose Maria Piulats, Matthias Goebeler, et al.
JCI Insight|April 29, 2025
Epac1 contributes to apremilast-mediated rescue of pemphigus autoantibody-induced loss of keratinocyte adhesionAnna M Sigmund, Franziska C Bayerbach, Daniela Kugelmann, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 4, 2020
Michael P Schön, Carola Berking, Tilo Biedermann, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 8, 2020
COVID-19 and immunological regulations - from basic and translational aspects to clinical implicationsMichael P Schön, Carola Berking, Tilo Biedermann, et al.
Frontiers in Immunology|December 27, 2021
NFAT5 Controls the Integrity of EpidermisKhalid Muhammad, Delicia Xavier, Stefan Klein-Hessling, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 4, 2007
Recommendations for the use of immunoapheresis in the treatment of autoimmune bullous diseasesDetlef Zillikens, Kurt Derfler, Rüdiger Eming, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 16, 2020
S2k guidelines for the treatment of pemphigus vulgaris/foliaceus and bullous pemphigoid: 2019 updateEnno Schmidt, Michael Sticherling, Miklós Sárdy, et al.
Expert Review of Clinical Immunology|April 29, 2025
Safety profile of efgartigimod from global clinical trials across multiple immunoglobulin G-mediated autoimmune diseasesKelly G Gwathmey, Catherine M Broome, Matthias Goebeler, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 16, 2020
Enno Schmidt, Michael Sticherling, Miklós Sárdy, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 28, 2015
S2k guidelines for the treatment of pemphigus vulgaris/foliaceus and bullous pemphigoidRüdiger Eming, Michael Sticherling, Silke C Hofmann, et al.
Pageof 31